Meriem Gaddas, Laurence Périn, & Yves Le Bouc. (2019). Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children. Galenos Yayincilik.
Chicago Style (17th ed.) CitationMeriem Gaddas, Laurence Périn, and Yves Le Bouc. Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children. Galenos Yayincilik, 2019.
MLA (9th ed.) CitationMeriem Gaddas, et al. Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children. Galenos Yayincilik, 2019.